Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Choline alphoscerate in clinical studies improved cognitive dysfunction in dementia, but it did not show any clear clinical benefit on mild cognitive impairment (MCI). There is limited evidence of neuropsychological markers in showing the effects of cholinergic precursors in MCI. Object of this preliminary study is to evaluate the change of the P300 latency as a biomarker for cognitive function after taking choline alphoscerate in patients with MCI. Event related evoked potential study were done in baseline (n = 27) and 3 months after taking choline alphoscerate (n = 17). When compared to our previous reported control database, the difference of the P300 latencies between MCI and control group at baseline was statistically significant (P < 0.01). Although Follow-up P300 latencies after taking choline alphoscerate did not show the significant change, the tendency of shortened P300 latencies was identified. Even though there are some limitations, choline alphoscerate could improve the electrophysiological markers in MCI patients. To identify the effect of cholinergic precursor in MCI and the usefulness of electrophysiological biomarkers, well-designed further study is needed.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007142 | PMC |
| http://dx.doi.org/10.1016/j.ensci.2018.04.004 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Lowering plasma S-Adenosylhomocysteine (SAH) in healthy adults with elevated SAH and normal homocysteine using nutritional supplementation.
Nutr Metab Cardiovasc Dis
July 2025
Nutrition Innovation Center, Standard Process Inc., Kannapolis, NC, USA. Electronic address:
Background And Aims: Elevated plasma levels of total homocysteine (Hcy) and S-Adenosylhomocysteine (SAH) are associated with increased risks of neurological and cardiovascular diseases (CVD). Whilst elevated plasma levels of Hcy can be managed through supplementation with B-group vitamins, there are no effective therapies for managing SAH in patients with elevated SAH and normal Hcy. SAH, a by-product of cellular methylation reactions, is considered a more sensitive biomarker for CVD than homocysteine (Hcy).
View Article and Find Full Text PDFCholine alphoscerate: insights between acquired certainties and future perspectives.
Front Aging Neurosci
August 2025
Department of Neuroscience and Mental Health, ASST Fatebenefratelli Sacco, Milan, Italy.
While mild cognitive impairment (MCI) is a risk factor for dementia, it is currently impossible to predict which patients will go on to develop dementia or Alzheimer's disease. Given the projected global increase in dementia due to an increasingly aging population, there is an urgent need to develop pharmacological therapies to reduce symptoms of MCI, and to help delay its possible progression to dementia. Choline alphoscerate is a cholinergic precursor naturally found in the brain that has been identified as an essential nutrient and is available as a prescription drug.
View Article and Find Full Text PDFTau Oligomers in Alzheimer's Disease: Modulation Effect of Osmolytes on Amplified Brain-Derived Tau Oligomers.
ACS Chem Neurosci
August 2025
Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, Texas 77555, United States.
Tau is bound to microtubules and plays a key role in their assembly and spatial organization. Under pathological conditions, tau detaches from the microtubules and develops a propensity to self-aggregate into soluble tau oligomers (TauO), paired helical filaments, and neurofibrillary tangles. Recent studies have revealed that TauO is the toxic species responsible for seeding, propagation, and development of tauopathies.
View Article and Find Full Text PDFL-Alpha-Glycerylphosphorylcholine (L-α-GPC): A Comprehensive Review of Its Preparation Techniques and Versatile Biological Effects.
J Food Sci
June 2025
State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi, Jiangsu, People's Republic of China.
L-alpha-glycerylphosphorylcholine (L-α-GPC), commonly referred to as glycerophosphorylcholine (GPC) or choline alfoscerate, is a choline-containing compound widely found in nature, predominantly in its L configuration. Due to its high choline content (41% by weight) and ability to cross the blood-brain barrier, GPC is considered one of the most utilized sources of choline. GPC, as a cholinergic compound with diverse applications across food, pharmaceutical, and cosmetics industries, faces limitations due to its restricted natural availability.
View Article and Find Full Text PDFStrong Dipole Inner Salt Molecule as Interface Ion Bridge for Rechargeable Aqueous Zn-Anode Batteries.
J Phys Chem Lett
April 2025
Key Laboratory of Advanced Energy Materials Chemistry (Ministry of Education), Engineering Research Center of High-efficiency Energy Storage (Ministry of Education), Frontiers Science Center for New Organic Matter, College of Chemistry, Nankai University, Tianjin 300071, P. R. China.
Aqueous electrolyte additives are effective to improve the Zn anode performance, but their structural effect on electric double layer and Zn plating remains elusive. By comparing several additives with varied compositions and polarities, we reveal that the dipole moment plays an important role in modulating the electrode interface, while zincophilic functional groups are crucial to Zn stripping/plating kinetics. A strongly dipolar inner salt, L-α-glycerylphosphorylcholine, is screened as a favorable additive to stabilize the hydrophobic surface of the Zn anode and act as a Zn-migration bridge for fast desolvation.
View Article and Find Full Text PDF